Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

The European Commission approved QDENGA (TAK-003) for use in individuals four years of age and older QDENGA becomes the only dengue vaccine approved in the EU for use in individuals regardless of previous dengue exposure Takeda (TSE:4502/NYSE:TAK) today announced that...

Read moreDetails
Page 304 of 322 1 303 304 305 322